Digg It
#1 in Business Subscribe Email Print

You are here: Home > Business > Management > How Roman Abramovich Became a Billionaire at Age 34, and Why Most Managers Struggle

Tags

  • packaged
  • risks
  • product
  • combination products
  • achieve those

  • Links

  • Celebrities - Cigarettes - Smoking
  • Article Writing For Clicks-Make Your Article Simple
  • Public Speaking: Roast Humor and Insults
  • Digg It - How Roman Abramovich Became a Billionaire at Age 34, and Why Most Managers Struggle

    When he was only 36 years old Roman Abramovich bought Chelsea Football Club. Within a year he had spent ?90m on new players and Chels
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    ea finished 4th in the league.

    Mr. Abramovich’s reaction was to fire the Manager in 2004 and bring in Portuguese coach Jose Marinho.
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    In 2005 Chelsea won the Premiership, The League Cup and the Community Shield. They also made the semi final of The Champions League.
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.


    Mr. Abromovich’s behavior differs from that of most other senior managers in four important ways.

    Do it Now

    He didn’t get to be a
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    illionaire at the age of 34 by putting off important issues until tomorrow. It is a sure bet that he never hesitates to do what needs
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    doing today. He is not a man to be deterred by constraints of budget, resources or other people’s attitudes or opinions.

    Make it hap
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    en

    Even the most cursory study of Mr Abramovich’s career shows that whenever he’s involved he makes a difference. He is not a man wh
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    o allows anything to deter him from what he wants to achieve; just look at what has happened in Chukotka province since he became Gov
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    rnor only 5 years ago.

    He employs the best people then gives them the best leaders, resources and coaches to make sure they deliver
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    o the highest standards.

    Build on Success

    Most managers do not seek to improve their team until things are going wrong or their peo
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    le are overloaded and stressed.

    Roman Abramovich brought in a first class coach when Chelsea were doing well but needed a little ext
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    a to make them into table toppers.

    This very successful business man deliberately builds on success - most ordinary managers only tr
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    to fix things when they think they’re going wrong.

    Provide the Resources to Achieve the Results

    When it comes to taking risks most
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    managers don’t want to know. “Safety first” is their motto. “Keep a low profile”. “Keep your head below the parapet”. “Don’t put your
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    wage packet at risk.” Such attitudes only ensure that their ideas are incinerated on the fires of corporate bureaucracy. Their passi
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    n is dissipated by their lack of courage to push their plans through to implementation.

    I would bet a lot of money that Roman Abramo
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    ich does not think about safety. I’ll bet that he focuses all his attention on the result he wants and that he makes it his business
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    o provide the resources necessary to achieve those results.

    What about you?

    Good questions to ask yourself are: Are you focused on
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    he results you need? Have your team got the resources they need to achieve those results? Are you allowing constraints of budget or c
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    mpany policy to hold you back? How big a player do you really want to be? What is it about the way you behave that’s holding you back


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/23779/diggit-How-Roman-Abramovich-Became-a-Billionaire-at-Age-34-and-Why-Most-Managers-Struggle.html">How Roman Abramovich Became a Billionaire at Age 34, and Why Most Managers Struggle</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/23779/diggit-How-Roman-Abramovich-Became-a-Billionaire-at-Age-34-and-Why-Most-Managers-Struggle.html]How Roman Abramovich Became a Billionaire at Age 34, and Why Most Managers Struggle[/url]

    Related Articles:

    Heavy Machinery Material Handling

    A Look at Deck Fasteners

    Business Failure in Ten Easy Steps

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com